These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8621603

  • 1. Prostaglandin A2 blocks the activation of G1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation.
    Hitomi M, Shu J, Strom D, Hiebert SW, Harter ML, Stacey DW.
    J Biol Chem; 1996 Apr 19; 271(16):9376-83. PubMed ID: 8621603
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2.
    Gorospe M, Liu Y, Xu Q, Chrest FJ, Holbrook NJ.
    Mol Cell Biol; 1996 Mar 19; 16(3):762-70. PubMed ID: 8622677
    [Abstract] [Full Text] [Related]

  • 3. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 4. p21Waf1 inhibits the activity of cyclin dependent kinase 2 by preventing its activating phosphorylation.
    Hitomi M, Shu J, Agarwal M, Agarwal A, Stacey DW.
    Oncogene; 1998 Aug 27; 17(8):959-69. PubMed ID: 9747875
    [Abstract] [Full Text] [Related]

  • 5. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
    Fukasawa K, Vande Woude GF.
    Mol Cell Biol; 1997 Jan 27; 17(1):506-18. PubMed ID: 8972231
    [Abstract] [Full Text] [Related]

  • 6. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 7. Cooperating oncogenes converge to regulate cyclin/cdk complexes.
    Lloyd AC, Obermüller F, Staddon S, Barth CF, McMahon M, Land H.
    Genes Dev; 1997 Mar 01; 11(5):663-77. PubMed ID: 9119230
    [Abstract] [Full Text] [Related]

  • 8. Effects of cyclin D1 overexpression on G1 progression-related events.
    Imoto M, Doki Y, Jiang W, Han EK, Weinstein IB.
    Exp Cell Res; 1997 Oct 10; 236(1):173-80. PubMed ID: 9344597
    [Abstract] [Full Text] [Related]

  • 9. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

  • 10. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB.
    Kidney Int; 1997 Apr 25; 51(4):1228-36. PubMed ID: 9083291
    [Abstract] [Full Text] [Related]

  • 11. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA, Rhodes N, Paules RS, Mudryj M.
    Oncogene; 1997 Jun 26; 14(25):3029-38. PubMed ID: 9223666
    [Abstract] [Full Text] [Related]

  • 12. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
    Gaben AM, Saucier C, Bedin M, Barbu V, Mester J.
    Int J Cancer; 2004 Jan 10; 108(2):200-6. PubMed ID: 14639603
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.
    Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250
    [Abstract] [Full Text] [Related]

  • 14. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1.
    Kerkhoff E, Rapp UR.
    Mol Cell Biol; 1997 May 06; 17(5):2576-86. PubMed ID: 9111327
    [Abstract] [Full Text] [Related]

  • 15. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM, Lents NH, Baldassare JJ.
    J Biol Chem; 2004 Feb 13; 279(7):5387-96. PubMed ID: 14645251
    [Abstract] [Full Text] [Related]

  • 16. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR.
    Nature; 1997 May 22; 387(6631):422-6. PubMed ID: 9163430
    [Abstract] [Full Text] [Related]

  • 17. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.
    Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ, Yang-Yen HF.
    Mol Cell Biol; 1995 Jul 22; 15(7):3654-63. PubMed ID: 7791772
    [Abstract] [Full Text] [Related]

  • 18. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
    Lepley DM, Pelling JC.
    Mol Carcinog; 1997 Jun 22; 19(2):74-82. PubMed ID: 9210954
    [Abstract] [Full Text] [Related]

  • 19. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
    Cheng M, Sexl V, Sherr CJ, Roussel MF.
    Proc Natl Acad Sci U S A; 1998 Feb 03; 95(3):1091-6. PubMed ID: 9448290
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
    Fiddes RJ, Janes PW, Sivertsen SP, Sutherland RL, Musgrove EA, Daly RJ.
    Oncogene; 1998 May 28; 16(21):2803-13. PubMed ID: 9652748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.